I can extract side effects.

Chapter 208

"Okay, okay. Hahaha!"

Ren Bin, the general manager of Daxia Zhizao, let out a hearty laugh after hanging up the phone.

He looked for the director of R&D with a radiant face: "Sanqing is generally quite satisfied with our sequencer, but they asked to send someone to optimize the algorithm and customize the kit to improve the accuracy of the data. You can find a few technical backbones, Hurry up and send it over."

"We must show that we attach importance to customers, and we will do what customers say!"

The director of research and development nodded and said yes, and quickly dispatched troops when he went back, and sent people to the Sanqing station.

A week later, Ren Bin crossed his legs in the office, drinking tea and watching the news.

Suddenly, the director of R&D rushed into the door: "Mr. Ren, it's done. Under the guidance of Sanqing, after improving the algorithm, the accuracy of the data has improved a lot, reaching 99.9%, which is the same as Immana. Sanqing said If we continue to optimize, this value can be further improved.”

Ren Bin was overjoyed: "Is it true? Have you verified it? Take me there to have a look."

When he came to the R&D department and saw the operating condition of the machine, he was full of surprises and walked around the site excitedly.

"Great, it's really not a loss to hug Sanqing's golden thigh."

"Quick, don't we have a batch of goods to be sent to the camel country soon? Hurry up and update the firmware and upgrade the new algorithm."

The R&D director hesitated: "This batch of goods has been packed and will be shipped tomorrow. Re-opening may delay the shipping schedule."

Ren Bin sternly said: "It's been dismantled, it's all dismantled, and the latest firmware must be upgraded. At all costs."

"Camel Country, as long as you tell them that the equipment has been upgraded with a new firmware and the data accuracy has reached a new level, it will definitely save costs and shorten the test time. Customers will be very happy, and they will not care about the delay in delivery time. Delayed for a few days."

"Mr. Ren is brilliant!" the R&D director praised.

Soon, a batch of new sequencers were packed in containers and traveled across the ocean to Camel Country.

After hearing the new news, the biologists in the camel country conducted a sequencing check on the new machine with suspicion, and the data results surprised them.

The accuracy has indeed been greatly improved. To know the value above 95%, it is difficult to increase it by a single point. I did not expect that the highest accuracy of 99.9% was directly mentioned this time.

In this way, there is no need for multiple sequencing, and the result can be produced once, which not only reduces the time, but also greatly saves the cost.

The person in charge of the Human Gene Bank of Camel Country was very happy. They had some complaints about Daxia's sequencer. They felt that although the cost was low, it was a bit troublesome to use and the accuracy was not very high. They were hesitant to continue buying.

Looking at it now, the upgraded new version works so well that it immediately signed a batch of new contracts with Daxia Zhizao.

The word of mouth of Great Xia Zhizao spread instantly in the desert country.

Since the release of the whole human genome, now every country with some strength is ready to move, wanting to establish its own national gene bank.

This has undoubtedly greatly increased the global sales of gene sequencers.

In addition to the big local tyrants like the camel country, there are also many other countries in the desert that want to build their own human gene pools.

After they visited the camel country, they found that the machines made by Daxia Zhizhi were really cheap, easy to use, and highly accurate, so they all placed orders.

Daxia Zhizao became famous in a short period of time, and sold more than a hundred machines, and overseas sales have greatly increased.

The most important thing is that their reputation in the third world countries has spread. Customers no longer only have the choice of Immena, but have considered Daxia Zhizao. If this continues, there will only be more and more customers in the future. .

In addition, Daxia Zhizao announced the cooperation plan with Sanqing, and announced the technical parameters and sequencing data of the latest machine, so that word of mouth skyrocketed, and domestic sales continued to increase.

During this period of time, in the sales department of Daxia Zhizao, the phone rang one after another without stopping, and countless inquiry emails flew over like snowflakes.

The sales managers were soft-spoken when they answered the phone, and they all spoke dryly, but they were as excited as if they had been beaten with chicken blood.

General Manager Ren Bin was even more elated. He quickly updated the financial statements. Not only did the revenue soar, but the number of customers at home and abroad also increased a lot. All the data are very good.

Subsequently, he resubmitted the listing application for the Science and Technology Innovation Board.

This time the listing application was successfully passed, and Daxia Zhizao was finally led by the golden thigh, and the IPO was successful.

As soon as it was listed, the stock price rose rapidly from 20 yuan, which has doubled several times, and stopped when it approached the [-] mark.

For a new stock, Daxia Zhizao has undoubtedly delivered an excellent result.

Such a performance also represents the optimism of capital and the confidence of the market.

As soon as the news came out, the share price of Immena plummeted.

Between the fall and the rise, there are really joys and sorrows for several families.

At the same time, Daxia Zhizao's competitor, the headquarters of Immena in Eagle Country California.

In a spacious conference room, executives gathered together with ugly expressions on their faces.

CEO Dr. Anthony, who is also one of the founders of the company, looked at everyone with a gloomy face at the moment.

"The successful listing of Daxia Zhizao is not good news. Now, it has become a strong opponent and is pressing harder and harder to attack us."

"Although their overseas market share is still very low, they cannot pose a threat to us, but in China, we have already lost 40% of the market. If this continues, we are likely to lose more."

"We cannot give up the Huaxia market easily. Do you have any suggestions?"

An executive said: "Patent, patent, or patent, I have seen the data of Daxia's new machine, and the gap with us is not too big. It is difficult to get rid of the opponent in the short term in terms of technology, and we have no advantage in terms of cost. For the current plan, we can only go all out and make a big fuss about patents."

"Daxia Zhizao has lawsuits with us in 12 countries around the world. We should make a fuss about this as much as possible, drag them down as much as possible, try to win the patent lawsuits, and drive them out of these markets."

"Even in Huaxia, we can't give up. We need to fight more patent lawsuits. This is where our advantage lies."

Dr. Anthony nodded approvingly: "Great, that's exactly what I thought."

He looked around and said slowly, "Any other suggestions?"

Another executive spoke eloquently: "We need to try our best to expand the upstream and downstream business, not only to be an upstream equipment manufacturer, but also to enter the mid-stream and downstream markets by acquiring companies, so as to form a whole industrial chain."

"In this way, not only will our moat be deeper and wider than our competitors, but our midstream and downstream businesses will also gain cost advantages."

An executive retorted: "We have entered the downstream cancer early screening market and acquired the 'Holy Grail' company, but it turns out that this move is not beneficial to the company, and the stock price has fallen by more than 20%."

"We are famous for our DNA sequencers, but we have been struggling to make clinical investments. Isn't this taking business from our own customers? Is this really good for the company?"

"If we compete with our customers in the downstream market, will customers still buy our equipment? They will just abandon us faster and buy equipment from competitors."

As soon as this remark came out, some people immediately objected: "But the downstream business market is bigger, the sequencer market is only a few billion dollars, but the cancer early screening market can reach [-] billion dollars, which is a gap of [-] times."

Dr. Anthony nodded: "That's right, we are already in a monopoly position in the sequencer market, and our development has come to an end. It is undeniable that the right direction is to develop into a larger downstream market."

He scanned the audience with deep eyes and made a conclusion: "Then let's fight back from the patent first, and then the cost should be reduced appropriately to win more customers."

"In the future, the battlefield between us and Daxia Zhizao will not only be the sequencer, but also the field of genetic testing."

"This is a brutal war. Although the opponent is still very weak, it is backed by a powerful country and has a vast market. It must not be underestimated."

(End of this chapter)